Nephros (NEPH) Stock Price

Nephros Price

NASDAQ·CLOSED
3.68
​
Market closed

Over the last 19 years Nephros grew revenue by 18.1% annually, reaching 18.79 M USD. For Nephros, the net margin of 6.4% is up versus -40.2% a few years ago. The consensus 12-month price target for Nephros is 7.14 USD, about 94.0% above where the stock trades today. Of 8 analysts, 7 rate the stock a buy — an overall Buy consensus.

Nephros stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Nephros business model & stock analysis

Nephros, Inc. is a medical device company, which engages in developing and selling liquid purification filters and an on-line mid dilution hemodiafiltration system. The company is headquartered in South Orange, New Jersey and currently employs 27 full-time employees. The company went IPO on 2004-09-21. The firm operates through two segments: Water Filtration and Renal Products. The Water Filtration segment primarily develops and sells high-performance water purification filters. The Renal Products segment is focused on the development of medical device products for patients with renal disease, including a second-generation hemodiafiltration system for the treatment of patients with end-stage renal disease (ESRD). The company develops and sells water filtration products used in both medical and commercial applications. The Company’s ultrafiltration products target the markets, including hospitals and other healthcare facilities, dialysis centers and home/portable dialysis machines, commercial facilities, and military and outdoor recreation. The Company’s subsidiaries include Biocon 1, LLC, Aether Water Systems, LLC and Specialty Renal Products, Inc.

Frequently asked questions about Nephros

Analysts currently set an average price target of 7.14 USD for the Nephros stock (median: 7.14 USD), implying +94.0 % versus the latest price. The consensus is based on 8 analyst ratings.

9 analysts currently rate the Nephros stock: 7 recommend buying, 2 holding and 0 selling. For 2026, analysts expect Nephros to generate revenue of 22.13 M USD and earnings per share of 0.15 USD.

Converted at the current exchange rate, the Nephros share trades at 3.28 EUR (3.68 USD).

The Nephros share (NEPH) is listed on 2 stock exchanges, including: NASDAQ (NEPH), Frankfurt (NPJP.F).

The expected revenue of Nephros is 22.13 M USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Nephros is 1.67 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Nephros is currently 24.24. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Nephros stock.

The price-to-sales ratio (P/S) of Nephros is currently 1.82. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Nephros stock.

The Eulerpool Quality Score for Nephros is 7/10.

The ISIN of Nephros is US6406714005. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Nephros is A2PNQ9. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Nephros is NEPH. The ticker symbol is used to trade Nephros shares on the stock exchange.

Fair ValueTerminal
3.50 USD
Over-/UndervaluationTerminal
Fairly valued
Industry
Household Durables
Number of shares
Employees
Revenue per Employee
695,888.89 USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website nephros.com
Currency
USD
Initial public offering
Sep 21, 2004
ISIN
US6406714005
Cusip
640671400
Market capitalization
39.12 M USDMicro Cap
52-Week Range
PEG
1.26
P/E ratio
P/Ee 2026
23.49
P/Ee 2027
14.15
P/Ee 2028
11.50
P/S
P/Se
1.82
EV/EBIT
30.35
P/B Ratio
3.83
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
10.60 %
Last updated Oct 20, 2026, 11:41 AM

Nephros Peer Group

Nephros Ticker

FRANKFURT · NPJP.FNASDAQ · NEPH

Nephros FIGI

NEPH:US · BBG000NXRTF2NEPH:UA · BBG000NXRTW3NEPH:UC · BBG000NXRVD9NEPH:UN · BBG000NXRW29NEPH:UP · BBG000NXRWS1NEPH:UB · BBG000NXSYT5NEPH:UM · BBG000NXSZZ5NEPH:UX · BBG000NXT0W4NEPH:UR · BBG000NXT296NEPH:PQ · BBG000NXT2T4NEPH:UV · BBG000NXT394NEPH:UD · BBG000NXT3Y6

All fundamentals and in-depth analysis of Nephros

Our stock analysis for Nephros stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Nephros. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.